![Ted Knous](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ted Knous
Direktor/Vorstandsmitglied bei University of Kansas
Aktive Positionen von Ted Knous
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Kansas | Direktor/Vorstandsmitglied | 31.03.2009 | - |
Karriereverlauf von Ted Knous
Ehemalige bekannte Positionen von Ted Knous
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Igxbio, Inc.
![]() Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Direktor/Vorstandsmitglied | 31.03.2009 | - |
Ausbildung von Ted Knous
University of Minnesota | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 2 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Igxbio, Inc.
![]() Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |